Turn this role into an interview — a resume and cover letter built around what this employer wants.
MoonLake Immunotherapeutics seeks an Incentive Compensation Lead to design and govern the field incentive program from the ground up. You will translate launch strategy into clear, fair and motivating plans; own payout governance, data quality and analytics for Sales and related field teams.
You will partner with Finance, HR, Legal/Compliance and Analytics to ensure transparency, defensibility and operational soundness; develop dashboards, govern vendor relationships and drive continuous
Build MoonLake's field incentive-compensation governance from the ground up. This role will translate launch strategy into clear, fair and motivating incentive plans; own payout governance and quality; and provide trusted performance analytics across Sales and other eligible field organizations.
Build MoonLake's field incentive-compensation governance from the ground up. This role will translate launch strategy into clear, fair and motivating incentive plans; own payout governance and quality; and provide trusted performance analytics across Sales and other eligible field organizations.
MoonLake is a dynamic and innovative company pushing the boundaries of possibility, and we are looking for passionate individuals to join our stellar team.
Learning Environment: An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Impactful Work: Contribute to ground-breaking projects that have the potential to transform global healthcare.
Flexibility and Balance: Enjoy a healthy work-life balance while making meaningful contributions to our team.
Career Growth: A clear path for career progression, with the chance to take on more responsibilities as you develop your skills.
is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.
We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com